Literature DB >> 34408355

Primary Extra-Uterine Endometrial Stromal Sarcoma and Synchronous Breast Cancer: A Double Whammy: A Case report.

Pavneet Kohli1, Prasanth Penumadu1, Neelesh Srivastava1, Bheemanathi Hanuman Srinivas2, Vidyalakshmi Rangarajan2.   

Abstract

Endometrial stromal sarcoma is an uncommon gynecological tumor. Extra-uterine endometrial stromal sarcoma (EESS), the extra-uterine variant of its relatively more common counterpart, is even rarer with only few documented case reports. We report a case of a 40-year woman with bilateral adnexal tumors and synchronous invasive ductal breast carcinoma (IDC) posing a diagnostic challenge. The histopathology of specimen confirmed the diagnosis of EESS in the absence of florid endometriosis and synchronous hormone-positive infiltrating duct cancer in the breast. Patient was started on adjuvant endocrine therapy and is disease free at the end of 2 years. To the best of our knowledge, this is the first documentation of synchronous presentation of IDC and EESS, highlighting the possible role of hyper-estrogenemia as an etiological factor. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  ESS; Extra-uterine endometrial stromal sarcoma; Uterine rare tumors; Uterine sarcoma

Year:  2021        PMID: 34408355      PMCID: PMC8310824          DOI: 10.1007/s13224-021-01437-6

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  4 in total

1.  Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases.

Authors:  Ramya P Masand; Elizabeth D Euscher; Michael T Deavers; Anais Malpica
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

2.  Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma.

Authors:  Esther Oliva; Jean-François Egger; Robert H Young
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

Review 3.  Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.

Authors:  Alon D Altman; Gregg S Nelson; Pamela Chu; Jill Nation; Prafull Ghatage
Journal:  Int J Gynecol Cancer       Date:  2012-07       Impact factor: 3.437

4.  Endometrial stromal sarcoma involving the urinary bladder: a study of 6 cases.

Authors:  Wei Tian; Mathieu Latour; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.